Management:

Designation:

Headquarters:

Website:

AbSci is a biotechnology company that specializes in developing a protein expression platform, called SoluPro, for the biopharmaceutical industry. Their platform aims to improve the speed, efficiency, and cost-effectiveness of producing complex proteins for use in therapeutic treatments. AbSci's technology involves genetically engineering E. coli bacteria to produce proteins with high purity and yield.

Management:

Designation:

Headquarters:

Website:

Acellera is a biotechnology company that provides computational solutions to accelerate drug discovery and development. Their flagship product, ACEMD, is a high-performance molecular dynamics simulation software that allows for the rapid and accurate analysis of molecular interactions, including protein-ligand binding and protein-protein interactions. Acellera's technology is designed to help pharmaceutical companies reduce the time and cost of bringing new drugs to market.

Management:

Designation:

Headquarters:

Website:

C4X Discovery is a biotechnology company that uses advanced computer technologies to discover and develop novel small-molecule drugs for a range of diseases. Their proprietary drug discovery platform, Conformetrix, utilizes X-ray crystallography and molecular modeling to create accurate 3D structures of drug targets, enabling the rapid and efficient design of new drug candidates.

Management:

Designation:

Headquarters:

Website:

Cyclica is a Canadian biotechnology company that specializes in using computational and systems biology to accelerate drug discovery and development. Their platform, Ligand Express, combines artificial intelligence and cloud computing to identify novel drug candidates and predict their efficacy, toxicity, and potential off-target effects.

Management:

Designation:

Headquarters:

Website:

e-therapeutics is a UK-based biotechnology company that uses network pharmacology and artificial intelligence to discover new drugs and repurpose existing drugs for the treatment of complex diseases. Their proprietary platform, Network-driven Drug Discovery (NDD), allows for the rapid and comprehensive analysis of disease networks and drug-target interactions to identify potential drug candidates.

Management:

Designation:

Headquarters:

Website:

Eitan Medical is reimagining drug delivery, with reliable innovations that put patients at the center of care, making drug delivery easier and safer than ever before. Patient safety and care are only the starting point, as Eitan Medical goes beyond- delivering connected, intuitive drug delivery and infusion solutions that are designed to improve patient and clinician quality of life.

Management:

Designation:

Headquarters:

Website:

Enveda Biosciences is a biotechnology company that uses artificial intelligence (AI) and machine learning (ML) to identify and develop new drugs. The company's AI platform is designed to analyze large datasets and identify potential drug targets that may have been missed using traditional methods. Enveda's platform combines expertise in genomics, and metabolomics to create a comprehensive understanding of disease pathways.

Management:

Designation:

Headquarters:

Website:

Nanopharm is a provider of tailored analytical and formulation support during all phases of drug development. The company has developed deep expertise in formulation development and troubleshooting for OINDPs. A range of clinically relevant analytical methods developed by Nanopharm also helps de-risk and even partially eliminate clinical trials, not least of which is a technology called SmartTrack™ which is a platform that can enable generic OIDP developers to demonstrate bioequivalence without enduring the risky, costly, and time-consuming comparative clinical endpoint studies.

Management:

Designation:

Headquarters:

Website:

Predictive Oncology is a company that specializes in the use of artificial intelligence (AI) and machine learning (ML) to improve the accuracy of cancer diagnosis and treatment. They provide a range of services including genomic analysis, drug discovery, and patient-specific cancer profiling. Their primary goal is to use their AI platform to help clinicians and researchers make better treatment decisions for cancer patients.

Management:

Designation:

Headquarters:

Website:

SCHOTT Pharmaceutical Systems, a global supplier of glass and polymer solutions for the pharmaceutical industry. Their products include vials, syringes, cartridges, and other packaging materials used for the safe and efficient storage and administration of drugs.